Iodine-123-metaiodobenzylguanidine scintigraphy in risk stratification of sudden death in heart failure

Iodine-123-metaiodobenzylguanidine scintigraphy in risk stratification of sudden death in heart failure

Metaiodobenzylguanidine (MIBG) is a false neurotransmitter noradrenaline analogue that is taken up by the ‘uptake 1’ transporter mechanism in the cell membrane of presynaptic adrenergic neurons and accumulates in catecholamine storage vesicles. Since it is practically unmetabolized, it can be labele...

Full description

Bibliographic Details
Main Authors:	Marta Inês Martins da Silva, Maria João Vidigal Ferreira, Ana Paula Morão Moreira
Format:	Article
Language:	English
Published:	Elsevier 2013-06-01
Series:	Revista Portuguesa de Cardiologia (English Edition)
Online Access:	http://www.sciencedirect.com/science/article/pii/S2174204913001104

Similar Items

Uptake index of 123I-metaiodobenzylguanidine myocardial scintigraphy for diagnosing Lewy body disease
by: Yoshito Kamiya, et al.
Published: (2017-01-01)

Standardization of 123I-metaiodobenzylguanidine cardiac neurotropic scintigraphy and single-photon emission tomography
by: A. A. Ansheles, et al.
Published: (2016-07-01)

Dosimetry estimation of SPECT/CT for iodine 123-labeled metaiodobenzylguanidine in children
by: Aida Mhiri, et al.
Published: (2015-09-01)

Complete remission of metastatic pheochromocytoma in 123I-metaiodobenzylguanidine scintigraphy after a single session of 131I-metaiodobenzylguanidine therapy: a case report
by: Teruaki Sugino, et al.
Published: (2017-12-01)

Changes in cardiac sympathetic nerve activity on 123I‐metaiodobenzylguanidine scintigraphy after MitraClip therapy
by: Keisuke Fukuda, et al.
Published: (2021-04-01)

Incidental detection of synchronous medullary thyroid carcinoma with bilateral adrenal pheochromocytoma on iodine-123 metaiodobenzylguanidine scintigraphy, leading to diagnosis of multiple endocrine neoplasia 2A
by: Asif Ali Fakhri, et al.
Published: (2017-01-01)

Stratification of the Risk of Sudden Death in Nonischemic Heart Failure
by: Maurício Pimentel, et al.
Published: (2014-10-01)

The significance of metaiodobenzylguanidine scintigraphy in the treatment of high risk neuroblastomas
by: Nikolić Katarina, et al.
Published: (2020-01-01)

Prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging in patients with indications for cardiac resynchronization therapy
by: Vytė Valerija Maneikienė, et al.
Published: (2014-08-01)

Elevated Heart Rate is Associated with Cardiac Denervation in Patients with Heart Failure: A 123-Iodine-MIBG Myocardial Scintigraphy Study
by: Aline Sterque Villacorta, et al.

Arrhythmias and sudden death in heart failure: electrical stratification of risk groups
by: Margarita Dorantes Sánchez, et al.
Published: (2019-01-01)

Risk Stratification of Sudden Cardiac Death in Patients with Heart Failure: An update
by: Daniele Masarone, et al.
Published: (2018-11-01)

123I-labeled metaiodobenzylguanidine for diagnosis of neuroendocrine tumors
by: Lei Jiang, et al.
Published: (2009-08-01)

The potential for early diagnosis of pulmonary arterial hypertension using lung iodine-123-metaiodobenzylguanidine (123I-MIBG) uptake: A case report
by: Kenjuro Higo, MDPhD, et al.
Published: (2020-08-01)

Risk stratification in sudden cardiac death : engineering novel solutions in heart failure
by: Rosengarten, James A.
Published: (2014)

The Prognostic Value of the Results of <sup>123</sup>I-metaiodobenzylguanidine Myocardial Scintigraphy in the Examination of Patients with Atrial Fibrillation Referred for Its Interventional Treatment
by: Yu. V. Varlamova, et al.
Published: (2019-11-01)

Cardiac I-metaiodobenzylguanidine Scintigraphy in a Patient with Familial Parkinsonism with Gene Mutation
by: Young-Do Kim, et al.
Published: (2010-10-01)

I-Metaiodobenzylguanidine Myocardial Scintigraphy in Lewy Body-Related Disorders: A Literature Review
by: Eun Joo Chung, et al.
Published: (2015-05-01)

Late gadolinium enhancement on cardiac magnetic resonance combined with 123I- metaiodobenzylguanidine scintigraphy strongly predicts long-term clinical outcome in patients with dilated cardiomyopathy.
by: Misato Chimura, et al.
Published: (2019-01-01)

Sudden death and pump failure death in heart failure
by: Shen, Li
Published: (2018)

Iodine-123-meta-iodobenzylguanidine Myocardial Scintigraphy in Isolated Autonomic Failure: Potential Red Flag for Future Multiple System Atrophy
by: Francesca Baschieri, et al.
Published: (2017-05-01)

Sudden cardiac death in ischemic heart disease. Pathophysiology and risk stratification
by: Nabil El-Sherif
Published: (2015-04-01)

Iodine-131 Metaiodobenzylguanidine Therapy for Neuroblastoma: Reports So Far and Future Perspective
by: Daiki Kayano, et al.
Published: (2015-01-01)

Risk stratification of sudden cardiac death in heart failure patients: is left ventricular ejection fraction alone sufficient?
by: N. N. Ilov, et al.
Published: (2021-02-01)

False Positive Radioiodinated Metaiodobenzylguanidine (123I-MIBG) Uptake in Undifferentiated Adrenal Malignant Tumor
by: Hee Soo Jung, et al.
Published: (2015-01-01)

Advanced Imaging in Chagas Heart Disease: From Diagnosis to Sudden Death Risk Stratification.
by: Rodríguez-Zanella H, et al.
Published: (2016-01-01)

Sudden cardiac death in hypertrophic cardiomyopathy: Improved risk stratification strategies are needed
by: Inês Cruz
Published: (2019-12-01)

Sudden cardiac death in hypertrophic cardiomyopathy: Improved risk stratification strategies are needed
by: Inês Cruz
Published: (2019-12-01)

Development of an 123I-metaiodobenzylguanidine Myocardial Three-Dimensional Quantification Method for the Diagnosis of Lewy Body Disease
by: Yoshito Kamiya, et al.
Published: (2018-06-01)

Radioiodine in Differentiated Thyroid Carcinoma: Do We Need Diagnostic Pre-Ablation Iodine-123 Scintigraphy to Optimize Treatment?
by: Elizabeth J. de Koster, et al.
Published: (2021-03-01)

Diagnostic accuracy of apparent diffusion coefficient and 123I-metaiodobenzylguanidine for differentiation of multiple system atrophy and Parkinson's disease.
by: Atsushi Umemura, et al.
Published: (2013-01-01)

Diagnostic Accuracy of Apparent Diffusion Coefficient and 123I-Metaiodobenzylguanidine for Differentiation of Multiple System Atrophy and Parkinson's Disease
by: Umemura, Atsushi
Published: (2015)

NEUROTROPIC MYOCARDIAL SCINTIGRAPHY IN THE EVALUATION OF SUDDEN CARDIAC DEATH PROGNOSIS IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
by: A. A. Ansheles, et al.
Published: (2017-09-01)

Sudden death prevention in heart failure: The case of CIBIS III
by: Ronnie Willenheimer, et al.
Published: (2006-09-01)

Incremental prognostic value of cardiac metaiodobenzylguanidine imaging over the co‐morbid burden in acute decompensated heart failure
by: Kiyomi Kayama, et al.
Published: (2021-04-01)

Review on Non-Invasive Risk Stratification of Sudden Cardiac Death
by: Jiang Ming Fam MBBS, MRCP (UK), MMed (Internal Med), et al.
Published: (2011-12-01)

RISK STRATIFICATION OF SUDDEN CARDIAC DEATH IN EARLY REPOLARIZATION SYNDROME
by: Shpak N. V., et al.
Published: (2019-11-01)

SUDDEN CARDIAC DEATH: PROBLEM OF RISK STRATIFICATION AND CHOICE OF THERAPY
by: E. V. Filippov, et al.
Published: (2016-01-01)

Galectin-3 and soluble ST2 as complementary tools to cardiac MRI for sudden cardiac death risk stratification in heart failure: A review
by: Niel N Shah, et al.
Published: (2020-09-01)

Sudden Cardiac Death in Patients with Heart Disease and Preserved Systolic Function: Current Options for Risk Stratification
by: Luigi Pannone, et al.
Published: (2021-04-01)

Cannot write session to /tmp/vufind_sessions/sess_0pf6o3qdaitimbioa6v4udn6ub